China Cord Blood Corp  

(Public, NYSE:CO)   Watch this stock  
Find more results for CO
5.13
+0.01 (0.20%)
Real-time:   1:20PM EDT
NYSE real-time data - Disclaimer
Currency in USD
Range 5.11 - 5.16
52 week 4.93 - 6.53
Open 5.13
Vol / Avg. 5,155.00/47,615.00
Mkt cap 399.61M
P/E 26.80
Div/yield     -
EPS 0.19
Shares 80.08M
Beta 0.56
Inst. own 24%
Nov 21, 2016
Q2 2017 China Cord Blood Corp Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Aug 23, 2016
Q1 2017 China Cord Blood Corp Earnings Call
Aug 22, 2016
Q1 2017 China Cord Blood Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '16) 2016
Net profit margin 9.36% 13.78%
Operating margin 30.14% 27.60%
EBITD margin - 36.42%
Return on average assets 1.37% 2.08%
Return on average equity 3.67% 5.60%
Employees 923 -
CDP Score - -

Address


+85236058180 (Phone)
+85236058181 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

China Cord Blood Corporation is a provider of cord blood banking services in China. The Company and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. It provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. It also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The Company provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. It also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants. As of March 31, 2016, the Company had three operating cord blood banks.

Officers and directors

Yuen Kam Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Ting Zheng Chief Executive Officer, Director
Age: 43
Bio & Compensation  - Reuters
Albert Chen Chief Financial Officer, Director
Age: 39
Bio & Compensation  - Reuters
Rui Arashiyama Chief Executive Officer - Guangdong and Zhejiang Divisions
Age: 56
Bio & Compensation  - Reuters
Yue Deng Chief Executive Officer - Beijing Division
Age: 45
Bio & Compensation  - Reuters
Xin Xu Chief Technology Officer
Age: 61
Bio & Compensation  - Reuters
Mark D. Chen Independent Non-Executive Director
Age: 47
Bio & Compensation  - Reuters
Ken Lu Independent Non-Executive Director
Age: 51
Bio & Compensation  - Reuters
Jennifer J. Weng Independent Non-Executive Director
Age: 47
Bio & Compensation  - Reuters